GlassScriptPhysician profile
Lisa Marie Mcdaniel
NPI 1932647450
$5,131.55
in general payments reported to CMS, 2019-2025
47 companies · $2,311 in 2025
The $2,311 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $596 · 2022: $529 · 2023: $783 · 2024: $912 · 2025: $2,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,681 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,680.72 |
| Education | $325.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $650.22 | 2021-2025 | |
| Janssen Biotech, INC. | $639.89 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Lilly USA, LLC | $625.63 | 2021-2025 | Taltz, Ebglyss, Mounjaro |
| Novo Nordisk INC | $413.39 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $309.96 | 2021-2025 | Repatha, Otezla, Otezla |
| Ucb, INC. | $269.70 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $211.13 | 2024-2025 | Sotyktu |
| Sanofi-Aventis U.S. LLC | $146.60 | 2021-2024 | |
| Leo Pharma INC. | $143.86 | 2024-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $142.78 | 2025 | Dupixent |
| Genzyme Corporation | $128.04 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $107.11 | 2021-2024 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $95.29 | 2021-2023 | Breztri, Flumist Quadrivalent, Farxiga |
| Incyte Corporation | $85.98 | 2024-2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.56 | 2021-2024 | Spevigo, Stiolto Respimat |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.